In future studies, we will combine bile acid receptor agonists or inhibitors to investigate the exact mechanism by which TACS regulate bile acid metabolism and gut microbiota to alleviate LF at the animal, cellular and molecular biology experiments. This evidence concerns the gene NR1H4 and Lassa fever.